Preview

Obstetrics, Gynecology and Reproduction

Advanced search

THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES

Full Text:

Abstract

Thromboembolism represents the most serious, potentially fatal complication of assisted reproductive technologies and in most cases is associated with ovarian hyperstimulation syndrome. This article describes the modern aspects of the pathogenesis of ovarian hyperstimulation syndrome, the pathogenesis of thromboembolic complications
and importance of genetic and acquired thrombophilia for their development, methods of risk assessment of thrombotic complications before using assisted reproductive technology and recommendations for prevention of thromboembolic complications in women enrolled in an IVF program.

About the Authors

S. V. Akinshina
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation


A. D. Makatsariya
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation


V. O. Bitsadze
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation


N. S. Stuleva
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation


T. Ya. Mashkova
First Moscow State Medical Sechenov University of the Ministry of Health Russian Federation
Russian Federation


References

1. Bitsadze V.O. Patogenez, printsipy diagnostiki i profilaktiki oslozhnenii beremennosti, obuslovlennykh trombofiliei. Dokt. Diss. (Pathogenesis, principles of diagnosis and prevention of complications of pregnancy, due to thrombophilia). Dr. diss. Moscow. 2004; 251 s.

2. Albert C., Garrido N., Mercader A., Rao C.V., Remohí J., Simón C., Pellicer A. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod. 2002 May; 8 (5): 409-18.

3. Avecillas J.F., Falcone T., Arroliga A.C. Ovarian hyperstimulation syndrome. Crit. Care Clin. 2004 Oct; 20 (4): 679-95.

4. Bates S.M., Greer I.A., Middeldorp S., Veenstra D.L., Prabulos A.M., Vandvik P.O. American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis. 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141 (2 Suppl): e691S-736S.

5. Chan W.S., Ginsberg J.S. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J. Thromb. Haemost. 2006 Aug; 4 (8): 1673-7.

6. Cluroe A.D., Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995 Oct; 27 (4): 344-6.

7. Colazingari S., Treglia M., Najjar R., Bevilacqua A. The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Arch. Gynecol. Obstet. 2013 May 25.

8. Delvigne A., Rozenberg S. Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome. Int. J. Fertil. Womens Med. 2002 Sep-Oct; 47 (5): 211-26.

9. Dulitzky M., Cohen S.B., Inbal A., Seidman D.S., Soriano D., Lidor A., Mashiach S.,Rabinovici J. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril. 2002 Mar; 77 (3): 463-7.

10. Enskog A., Henriksson M., Unander M., Nilsson L., Brannstrom M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999 May; 71 (5): 808-14.

11. Felberbaum R.E., Diedrich K. Gonadotrophinreleasing hormone antagonists: will they replace the agonists? Reprod. Biomed. Online. 2003 Jan-Feb; 6 (1): 43-53.

12. Gerli S., Papaleo E., Ferrari A., Di Renzo G.C. Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS. Eur. Rev. Med. Pharmacol. Sci. 2007; 11 (5): 347-354.

13. Kodama H., Fukuda J., Karube H., Matsui T., Shimizu Y., Tanaka T. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil. Steril. 1996 Sep; 66 (3): 417-24.

14. Nelson S.M., Greer I.A. The potential role of heparin in assisted conception. Hum. Reprod. Update. 2008 Nov-Dec; 14 (6): 623-45.

15. Ou Y.C., Kao Y.L., Lai S.L., Kung F.T., Huang F.J., Chang S.Y., ChangChien C.C. Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: case report. Hum. Reprod. 2003 Nov; 18 (11): 2375-81.

16. Qublan H.S., Eid S.S., Ababneh H.A., Amarin Z.O., Smadi A.Z., Al-Khafaji F.F., Khader Y.S. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum. Reprod. 2006 Oct; 21 (10): 2694-8.

17. Rao A.K., Chitkara U., Milki A.A. Subclavian vein thrombosis following IVF and ovarian hyperstimulation: a case report. Hum. Reprod. 2005 Dec; 20 (12): 3307-12.

18. Ricci G., Cerneca F., Simeone R., Pozzobon C., Guarnieri S., Sartore A., Pregazzi R., Guaschino S. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an openlabel, randomized, controlled trial. Hum Reprod. 2004 Apr; 19 (4): 838-48.

19. Rizk B., Aboulghar M., Smitz J., Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997 May-Jun; 3 (3): 255-66.

20. Rogolino A., Coccia M.E., Fedi S., Gori A.M., Cellai A.P., Scarselli G.F., Prisco D., Abbate R. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood. Coagul. Fibrinolysis. 2003 Apr; 14 (3): 277-82.

21. Yan Z., Weich H.A., Bernart W., Breckwoldt M., Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J. Clin. Endocrinol. Metab. 1993 Dec; 77 (6): 1723-5.

22. Yoshii F., Ooki N., Shinohara Y., Uehara K., Mochimaru F. Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome. Neurology. 1999 Jul 13; 53 (1): 225-7.

23.

24.


For citation:


Akinshina S.V., Makatsariya A.D., Bitsadze V.O., Stuleva N.S., Mashkova T.Y. THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES. Obstetrics, Gynecology and Reproduction. 2014;8(2):89-96. (In Russ.)

Views: 190


ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)